Patents-Review.com
ClassID:

20023 ⎘

A61K9/0026 - CPC Classification

Classification description:

Medicinal preparations characterised by special physical form; Galenical forms characterised by the site of application; Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner Blood substitute; Oxygen transporting formulations; Plasma extender

Recent Application in this class:
#1
20250367268
2025-12-04

Compositions and Methods for Treating Internal Bleeding and Hemorrhage

 #2
20250345276
2025-11-13

O/W-EMULSIONS COMPRISING SEMIFLUORINATED ALKANES

 #3
20250332106
2025-10-30

Spray-dried blood products and methods of making same

 #4
20250312383
2025-10-09

HUMAN UMBILICAL CORD BLOOD FOR USE IN ALLEVIATING FATIGUE

 #5
20250064942
2025-02-27

ARTIFICIAL OXYGEN CARRIER BLOOD PRODUCT

 #6
20250064724
2025-02-27

MODULAR FIELD-STABLE BIO-ARTIFICIAL BLOOD SUBSTITUTE

 #7
20240294609
2024-09-05

STABILIZED HEMOGLOBIN COMPOSITIONS AND PHARMACEUTICAL FORMULATIONS THEREOF

 #8
20230277461
2023-09-07

OXYGEN-CONTAINING PARTICLES, MANUFACTURING METHOD THEREFOR, AND USE THEREOF

 #9
20230241184
2023-08-03

Compositions and Methods for Treating Hemorrhagic Shock

 #10
20230139672
2023-05-04

O/W-EMULSIONS COMPRISING SEMIFLUORINATED ALKANES

 #11
20230124172
2023-04-20

PLANT MEDIUM INCLUDING AN OXYGEN-ENABLED COMPOSITION

 #12
20230090172
2023-03-23

BLOOD SUBSTITUTES COMPRISING HEMOGLOBIN AND METHOGS OF MAKING

 #13
20220354930
2022-11-10

Hemoglobin Substitute Mixtures Including Reconstituted Plasma and Platelets and Their Manufacture and Use

 #14
20220202940
2022-06-30

METHOD OF STABILIZING A DIALYSIS SOLUTION

 #15
20220168337
2022-06-02

PRODUCING ATP AND IMPROVING MITOCHONDRIAL FUNCTION IN A MAMMAL USING A POLY-OXYGENATED METAL HYDROXIDE

 #16
20220117897
2022-04-21

Spray-Dried Blood Products and Methods of Making Same

 #17
20220105034
2022-04-07

Microbubble dispersion system stabilized with polydopamine nanoparticles for highly-efficient intravenous oxygen supply and method for preparing the same

 #18
20220040237
2022-02-10

OXYGENATED DEMINERALIZED BONE MATRIX FOR USE IN BONE GROWTH

 #19
20210393517
2021-12-23

BODY FLUID EXPANDERS COMPRISING N-SUBSTITUTED AMINOSULFONIC ACID BUFFERS

 #20
20210379206
2021-12-09

COMPOSITIONS AND METHODS FOR MEASURING AND EXPANDING BLOOD VOLUME

 #21
20210369846
2021-12-02

New Ammonium Salts Of Fluorinated Organic Acids, Method Of Their Synthesis and Application

 #22
20210060063
2021-03-04

Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products

 #23
20210015853
2021-01-21

Mitochondrial Function using a Poly-Oxygenated Metal Hydroxide

 #24
20210015852
2021-01-21

Plant medium including an oxygen-enabled composition

 #25
20200360285
2020-11-19

O/W-EMULSIONS COMPRISING SEMIFLUORINATED ALKANES

 #26
20200345762
2020-11-05

METHOD AND SYSTEM FOR PROVIDING PERITONEAL DIALYSIS FLUIDS WITH VARYING SODIUM CONCENTRATIONS

 #27
20200281858
2020-09-10

System and method for freeze-drying and packaging

 #28
20200261495
2020-08-20

LIQUID OXYGEN ENCAPSULATION AND METHODS TO ADMINISTER INTRAVASCULAR LIQUID OXYGEN

 #29
20200222510
2020-07-16

Blood substitutes comprising hemoglobin and methods of making

 #30
20200163903
2020-05-28

Buffered Oxygen Therapeutic

 #31
20200000941
2020-01-02

Compositions and methods for measuring and expanding blood volume

 #32
20190388337
2019-12-26

PROCESS FOR FORMING MICROBUBBLES WITH HIGH OXYGEN CONTENT AND USES THEREOF

 #33
20190298759
2019-10-03

Plant medium including an oxygen-enabled composition

 #34
20190282617
2019-09-19

Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products

 #35
20190255099
2019-08-22

POLY-OXYGENATED METAL HYDROXIDE AND CBD

 #36
20190224123
2019-07-25

O/W-EMULSIONS COMPRISING SEMIFLUORINATED ALKANES

 #37
20190183982
2019-06-20

POLYMERIC RED BLOOD CELL-LIKE PARTICLES

 #38
20190167729
2019-06-06

OXYGENATED DEMINERALIZED BONE MATRIX FOR USE IN BONE GROWTH

 #39
20190038665
2019-02-07

Plant medium including an oxygen-enabled composition

 #40
20180311280
2018-11-01

Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products

 #41
20180271900
2018-09-27

Reducing the proliferation of lung carcinoma cells (A549) by administration of a poly-oxygenated metal hydroxide

 #42
20180271899
2018-09-27

Oxygen-enabled composition

 #43
20180264035
2018-09-20

Reducing the proliferation of adenocarcinoma cells (CaCo-2) by administration of a poly-oxygenated metal hydroxide

 #44
20180264034
2018-09-20

Reducing the proliferation of carcinoma cells by administration of a poly-oxygenated metal hydroxide

 #45
20180256613
2018-09-13

Nanoemulsion synthetic red blood cells having sequentially formed calcium phosphate coating and preparation method thereof

 #46
20180243344
2018-08-30

OXYGENATED DEMINERALIZED BONE MATRIX FOR USE IN BONE GROWTH

 #47
20180186857
2018-07-05

Factor VIII protein compositions and methods of treating of hemophilia A

 #48
20180169149
2018-06-21

OXYGENATED DEMINERALIZED BONE MATRIX FOR USE IN BONE GROWTH

 #49
20180169139
2018-06-21

COMPOSITION AND METHODS FOR TREATMENT OF LOSS OF FLUIDS LEADING TO HYPOTENSION AND/OR HYPOVOLEMIA

 #50
20180153811
2018-06-07

Spray-dried blood products and methods of making same

 #51
20180147111
2018-05-31

MEDICAL PROTOCOL FOR IMPROVING HUMAN SEXUAL FUNCTION

 #52
20180071334
2018-03-15

REDUCING THE PROLIFERATION OF CARCINOMA CELLS BY ADMINISTRATION OF A POLY-OXYGENATED METAL HYDROXIDE

 #53
20180055763
2018-03-01

Rheological blood replacement solution and uses thereof

 #54
20180021266
2018-01-25

Buffered oxygen therapeutics

 #55
20170367990
2017-12-28

Use of nanoparticles coated with red blood cell membranes to enable blood transfusion

 #56
20170304281
2017-10-26

METHODS OF USING POTASSIUM CHANNEL INHIBITORS (BLOCKERS) FOR FLUID RESUSCITATION

 #57
20170281675
2017-10-05

Oxygen-enabled fluid

 #58
20170281544
2017-10-05

Oxygen-enabled composition

 #59
20170105929
2017-04-20

BIODEGRADABLE NANOPARTICLES AS NOVEL HEMOGLOBIN-BASED OXYGEN CARRIERS AND METHODS OF USING THE SAME

 #60
20170042804
2017-02-16

Polymer-based serum albumin substitute

 #61
20160346407
2016-12-01

Compositions and methods for measuring and expanding blood volume

 #62
20160346358
2016-12-01

Blood substitute composition and method of use

 #63
20160310414
2016-10-27

MICROPARTICLES, BLOOD SUBSTITUTE AND METHOD FOR FORMING SAME

 #64
20160303049
2016-10-20

Nanoparticle fabrication methods, systems, and materials for fabricating artificial red blood cells

 #65
20160106778
2016-04-21

Multipart fluid system and a system for citrate anticoagulation in an extracorporeal blood circuit

 #66
20160051635
2016-02-25

Blood substitute composition and method of use

 #67
20150374752
2015-12-31

COMPOSITION OF DIALYSIS LIQUID COMPRISING CRYSTALLISATION INHIBITOR SUBSTANCES

 #68
20150321204
2015-11-12

Method and apparatus for continuous removal of sub-micron sized particles in a closed loop liquid flow system

 #69
20150238432
2015-08-27

Synthesis of oxygen carrying, turbulence resistant, high density submicron particulates

 #70
20150164787
2015-06-18

Process for forming microbubbles with high oxygen content and uses thereof

 #71
20150139964
2015-05-21

Body fluid expanders comprising N-substituted aminosulfonic acid buffers

 #72
20140371329
2014-12-18

Buffered oxygen therapeutic

 #73
20140302166
2014-10-09

Composition of dialysis liquid comprising crystallisation inhibitor substances

 #74
20140112961
2014-04-24

Methods and compositions for treating conditions related to lack of blood supply, shock, and neuronal injuries

 #75
20130336884
2013-12-19

Nanoparticle fabrication methods, systems, and materials for fabricating artificial red blood cells

 #76
20130307170
2013-11-21

Blood substitutes and uses thereof

 #77
20130243688
2013-09-19

Anionic lipids and lipid nano-structures and methods of producing and using same

 #78
20130230602
2013-09-05

Devices and methods for making and administering an intravenous liquid with supersaturated dissolved gas

 #79
20130096204
2013-04-18

Buffered oxygen therapeutic

 #80
20130095192
2013-04-18

Resuscitation fluid

 #81
20130066264
2013-03-14

SUGAR-RESPONSIVE GEL AND MEDICINE ADMINISTERING DEVICE

 #82
20130005685
2013-01-03

Starch derivative mixtures

 #83
20120282234
2012-11-08

Medium, solutions and methods for the washing, culturing and storage of white blood cells

 #84
20120201900
2012-08-09

Systems, methods, and devices for microbubbles

 #85
20120164231
2012-06-28

Synthesis Of Oxygen Carrying, Turbulence Resistant, High Density Submicron Particulates

 #86
20120087956
2012-04-12

Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries

 #87
20120082704
2012-04-05

Oxygenated demineralized bone matrix for use in bone growth

 #88
20120077662
2012-03-29

Method And Apparatus For Continuous Removal Of Submicron Sized Particles In A Closed Loop Liquid Flow System

 #89
20120034277
2012-02-09

Resuscitation fluid

 #90
20120028235
2012-02-02

Resuscitation fluid

 #91
20120027867
2012-02-02

Spray-dried blood products and methods of making same

 #92
20110311644
2011-12-22

Plasma-adapted full electrolyte solution

 #93
20110306581
2011-12-15

Stable perfluorocarbon emulsion for use as an artificial oxygen carrier

 #94
20110300193
2011-12-08

Method for increasing the volume of a blood substitute with an expander comprising basic alpha keratose

 #95
20110257090
2011-10-20

SOLUTIONS FOR VOLUME THERAPY

 #96
20110256225
2011-10-20

Biodegradable nanoparticles as novel hemoglobin-based oxygen carriers and methods of using the same

 #97
20110229575
2011-09-22

DEEP IMMERSION FLOTATION THERAPY FOR BURN VICTIMS

 #98
20110223243
2011-09-15

Artificial oxygen carriers and use thereof

 #99
20110172194
2011-07-14

Composition of dialysis liquid comprising crystallisation inhibitor substances

 #100
20110091863
2011-04-21

Blood substitute solution

 #101
20110059157
2011-03-10

Anionic lipids and lipid nano-structures and methods of producing and using same

 #102
20110052708
2011-03-03

METHODS AND FORMULATIONS FOR THE DELIVERY OF PHARMACOLOGICALLY ACTIVE AGENTS

 #103
20100298445
2010-11-25

Optimized fluorocarbon emulsions for blood substitutes and other therapeutic uses

 #104
20100298266
2010-11-25

Hydroxyethylstarch

 #105
20100209532
2010-08-19

TARGETED OXYGEN DELIVERY VIA INTRAVENOUS OR INTRA-ARTERIAL INFUSION OF OXYGENATED POLYMERIZED HEMOGLOBIN SOLUTIONS

 #106
20100209518
2010-08-19

Micro-particles, blood-substitute and method for forming same

 #107
20100196461
2010-08-05

RESUSCITATION FLUID

 #108
20100183747
2010-07-22

BODY FLUID EXPANDERS COMPRISING N-SUBSTITUTED AMINOSULFONIC ACID BUFFERS

 #109
20100183561
2010-07-22

Biological therapeutic compositions and methods thereof

 #110
20100178347
2010-07-15

Method of treating traumatic brain injury

 #111
20100145298
2010-06-10

OXYGEN-CARRYING BLOOD SUBSTITUTE PREPARATIONS

 #112
20100144597
2010-06-10

Novel combinatorial approaches to enhancing oxygen transport to tissues

 #113
20100056974
2010-03-04

Bone metabolism improving agent

 #114
20100028994
2010-02-04

Nanoparticle fabrication methods, systems, and materials for fabricating artificial red blood cells

 #115
20090163418
2009-06-25

Resuscitation fluid

 #116
20090048331
2009-02-19

METHODS AND FORMULATIONS FOR THE DELIVERY OF PHARMACOLOGICALLY ACTIVE AGENTS

 #117
20090017001
2009-01-15

Method for increasing plasma volume by administering a plasma expander comprising basic alpha keratose

 #118
20080292579
2008-11-27

Polymer-based serum albumin substitute

 #119
20080269124
2008-10-30

Stabilizer molecule-depleted albumin solution

 #120
20080262413
2008-10-23

Method For Supplying Oxygenated Water To Promote Internal Healing

 #121
20080220406
2008-09-11

Physiologically acceptable aqueous solutions and methods for their use

 #122
20080193516
2008-08-14

OXYGEN-CARRYING BLOOD SUBSTITUTE PREPARATIONS

 #123
20070282014
2007-12-06

Hydroxyethylstarch

 #124
20070197475
2007-08-23

Medical emulsion of perfluororganic compounds and method for the production thereof

 #125
20070196526
2007-08-23

Agent for substitution of blood plasma and a method of its production

 #126
20070178435
2007-08-02

Composition for maintaining organ and cell viability

 #127
20070042338
2007-02-22

Method for sorting tumor cells

 #128
20070026024
2007-02-01

Compositions and methods for emulsifying a pefluorocarbon with an oxygen-carrying surfactant

 #129
20060257326
2006-11-16

Methods and formulations for delivery of pharmacologically active agents

 #130
20060249456
2006-11-09

Method of removing carbon monoxide from an oxygen carrier and apparatus for removing carbon monoxide

 #131
20060241170
2006-10-26

Methods and formulations of taxanes

 #132
20060182807
2006-08-17

Copolymer and hemoprotein based novel compounds and uses thereof

 #133
20060088583
2006-04-27

Artificial oxygen carrier containing preventive agents of metHb formation

 #134
20060083782
2006-04-20

Methods and compositions useful for administration of chemotherapeutic agents

 #135
20060073175
2006-04-06

Methods and formulations for delivery of pharmacologically active agents

 #136
20060051732
2006-03-09

Ambient stored blood plasma expanders containing keratose

 #137
20050256211
2005-11-17

Patient oxygenation using stabilized fluorocarbon emulsions

 #138
20050119161
2005-06-02

Methods and compositions for oxygen transport comprising an oxygen carrier and a crystalloid in hypertonic solution

 #139
20050037330
2005-02-17

Composition for maintaining organ and cell viability

 #140
20050025757
2005-02-03

Oxygen carrier system, artificial oxygen carrier, and reducing agent